Meridian to Collaborate with Thorne Research on Promotional Information Distribution

VANCOUVER, British Columbia

Meridian Co., Ltd.
Greg Worobec
Corporate Communications
1-877-738-8119

Meridian Co., Ltd. ("Meridian" or the "Company") (OTCBB:MRDAF), is pleased to announce that Thorne Research, Inc. ("Thorne") has offered to promote the Digital Pulse Analyzer ("DPA") by including Meridian's promotional literature with its product orders and mail-outs to physicians across North America. Over a 30-day period Thorne will distribute 10,000 Meridian brochures along with Thorne's latest product and company information.

The two companies met in September 2004 and have since realized their collaborative potential, combining Meridian's technology and Thorne's superior cardiovascular product. Thorne's new product - Perfusia-SR represents a revolutionary advancement in nutritional support for the heart and blood vessels. Perfusia-SR is a proprietary sustained-release L-arginine, which provides the body a constant source of nitric oxide, a substance vital in many metabolic processes in the body, especially the lining of the arteries.

The DPA has the capability to measure the efficacy of treatment programs, including neutraceutical supplementation, by accurately measuring the elasticity of small and large artery compliance, which provides critical information regarding arterial health and aging.

More About: Digital Pulse Analyzer ("DPA")

The DPA is an FDA approved device that is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

The Company feels that use of the "DPA" can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry. Cardiovascular disease is the #1 killer in the United States with an estimated economic cost of approximately $298 billion.

More About: Thorne

Since 1984, Thorne has earned the trust of thousands of health-care practitioners worldwide. Confidence in Thorne is the single most important reason practitioners turn to their products for their critical nutritional supplement needs.

In this competitive industry the amount of dollars spent on advertising is tremendous, with all companies claiming they have the best products. Thorne's reputation wasn't shaped through clever marketing, but rather, through the unbiased scrutiny and approval of health-care practitioners throughout the world who discovered one important detail - their products consistently produced positive results in their patients.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of its products.

Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.

Website (Korean): www.meridian.co.kr

Website (North America): meridianmedical.ca